HAE: Clinical Trials

3 trials for HAE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2

Follow HAE: new trials by email Literature Review of HAE trials Research Report on HAE

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Long Term Safety Study of BCX7353 in Hereditary Angioedema
BCX7353 - Hereditary Angioedema, HAE
Phase 2 / Phase 3CompletedBioCryst Pharmaceuticals3872018-02-162023-06-18
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
BCX7353 capsules, Placebo oral capsule - Hereditary Angioedema, HAE
Phase 3CompletedBioCryst Pharmaceuticals1212018-02-062023-06-26
12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks
BCX4161, Placebo - Hereditary Angioedema, HAE
Phase 2 / Phase 3CompletedBioCryst Pharmaceuticals1102014-12-172025-11-17

Narrower conditions

Angioedemas, Hereditary (3)

Broader conditions

Angioedema (3)  ·  Cardiovascular Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hereditary Complement Deficiency Diseases (3)  ·  Hypersensitivity (3)  ·  Hypersensitivity, Immediate (3)  ·  Immune System Diseases (3)  ·  Immunologic Deficiency Syndromes (3)  ·  Primary Immunodeficiency Diseases (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Vascular (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Urticaria (3)  ·  Vascular Diseases (3)

Interventions

berotralstat (2)  ·  avoralstat (1)

Sponsors

BioCryst Pharmaceuticals (3)

Countries

France (3)  ·  Germany (3)  ·  Hungary (3)  ·  United Kingdom (3)  ·  United States (3)  ·  Austria (2)  ·  Canada (2)  ·  Italy (2)  ·  North Macedonia (2)  ·  Spain (2)  ·  Australia (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Hong Kong (1)

Top investigators

Bruce Zuraw, MD (1)  ·  Henriette Farkas, MD (1)  ·  Marc Riedl, MD MS (1)

Results publications

PMID 36326435, PMID 36408587, PMID 33098856, PMID 33866032, PMID 34161665, PMID 35820771, PMID 38006972, PMID 38020288, PMID 40490218